Acquired haemophilia A;Verworven hemofilie A

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 27, 1997, Pages 1342-1344

  Brouwer, R E ^a   Huisman, M V ^a   Feuth, J D M ^a   Van Der Meer, F J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACQUIRED HEMOPHILIA A; AGED; ARTICLE; CASE REPORT; FOLLOW UP; GOOD CLINICAL PRACTICE; HEMOPHILIA A; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NETHERLANDS; PATIENT CARE;

AGED; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME;

EID: 0030816158     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, Eys J van, et al. Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975;34:612.
2. Lavergne JM, Meyer D, Reisner H. Characterization of human antifactor VIII antibodies purified by immune complex formation. Blood 1976;48:931-9.
3. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981;45:200-3.
4. Gatti L, Mannucci PM. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. Thromb Haemost 1984;51:379-84.
5. Lusher JM, Shapiro SS, Palascak JE, Rao A V, Levine PH, Blatt PM. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII. N Engl J Med 1980;303:421-5.
6. Hilgartner MW, Knatterud GL. The use of factor eight inhibitor bypassing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors. Blood 1983;61:36-40.
7. Hilgartner MW, Aledort L, Andes A, Gill J. Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. FEIBA Study Group.Transfusion 1990;30:626-30.
8. Hay CRM, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor Vila [abstract]. Hemophilia 1996;2:157.
9. Lian EC, Larcada AF, Chiu AY. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989;110:774-8.
10. Green D, Rademaker AW, Briët E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993;70:753-7.
11. Green D. High dose intravenous gammaglobulin for spontaneous inhibitors of factor VIII:C [abstract]. Blood 1988;172 Suppl:297a.
12. Heyman MR, Chakravarthy A, Edelman BB, Needleman SW, Schiffer CA. Failure of high-dose i.v. gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitors. Am J Hematol 1988;28:191-4.
13. Coller BS, Hultin MB, Hoyer LW, Miller F, Dobbs JV, Dosik MH, et al. Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor. Blood 1981;58:619-24.
14. Voke J, Letsky E. Pregnancy and antibody to factor VIII. J Clin Pathol 1977;30:928-32.
15. Michiels JJ, Bosch LJ, Plas PM van der, Abels J. Factor VIII inhibitor postpartum. Scand J Haematol 1978;20:97-107.